FI961440A0 - Cellinjer som avsöndrar insulin, framställningsförfaranden och användning - Google Patents

Cellinjer som avsöndrar insulin, framställningsförfaranden och användning

Info

Publication number
FI961440A0
FI961440A0 FI961440A FI961440A FI961440A0 FI 961440 A0 FI961440 A0 FI 961440A0 FI 961440 A FI961440 A FI 961440A FI 961440 A FI961440 A FI 961440A FI 961440 A0 FI961440 A0 FI 961440A0
Authority
FI
Finland
Prior art keywords
pct
cell line
insulin
sec
beta
Prior art date
Application number
FI961440A
Other languages
English (en)
Finnish (fi)
Other versions
FI961440A (sv
Inventor
Maryam Asfari
Paul Czernichow
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI961440A0 publication Critical patent/FI961440A0/sv
Publication of FI961440A publication Critical patent/FI961440A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FI961440A 1993-09-30 1996-03-29 Cellinjer som avsöndrar insulin, framställningsförfaranden och användning FI961440A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9311687A FR2710654B1 (fr) 1993-09-30 1993-09-30 Nouvelles lignées de cellules sécrétrices d'insuline, leurs procédés d'obtention par voie de manipulation génétique et leur utilisation chez des sujets diabétiques sous forme protégée.
PCT/FR1994/001129 WO1995009231A1 (fr) 1993-09-30 1994-09-27 Lignees de cellules secretrices d'insuline, procedes d'obtention et utilisation

Publications (2)

Publication Number Publication Date
FI961440A0 true FI961440A0 (sv) 1996-03-29
FI961440A FI961440A (sv) 1996-03-29

Family

ID=9451437

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961440A FI961440A (sv) 1993-09-30 1996-03-29 Cellinjer som avsöndrar insulin, framställningsförfaranden och användning

Country Status (17)

Country Link
US (1) US5902577A (sv)
EP (1) EP0721500B1 (sv)
JP (2) JPH09503662A (sv)
KR (2) KR100463366B1 (sv)
CN (1) CN1078248C (sv)
AT (1) ATE299930T1 (sv)
AU (1) AU688383B2 (sv)
BR (1) BR9407682A (sv)
CA (1) CA2172997A1 (sv)
DE (1) DE69434433T2 (sv)
DK (1) DK0721500T3 (sv)
ES (1) ES2243929T3 (sv)
FI (1) FI961440A (sv)
FR (1) FR2710654B1 (sv)
HU (1) HU219826B (sv)
NO (1) NO317236B1 (sv)
WO (1) WO1995009231A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
US6642003B2 (en) 2001-08-02 2003-11-04 Cedars-Sinai Medical Center Human glucose-dependent insulin-secreting cell line
WO2003050249A2 (en) * 2001-12-07 2003-06-19 Geron Corporation Islet cells from human embryonic stem cells
US7141240B2 (en) * 2002-03-12 2006-11-28 Cedars-Sinai Medical Center Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
US8415153B2 (en) 2006-06-19 2013-04-09 Geron Corporation Differentiation and enrichment of islet-like cells from human pluripotent stem cells
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN109957539A (zh) * 2017-12-14 2019-07-02 深圳先进技术研究院 一种人造胰岛组织及其制备和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229526B4 (de) * 1992-09-07 2006-02-16 Schrezenmeir, Jürgen, Dr. Vorrichtung zur Aufnahme und zum Einbringen von biologisch aktiven Geweben oder Zellen in den menschlichen Körper

Also Published As

Publication number Publication date
JPH09503662A (ja) 1997-04-15
NO961268L (no) 1996-03-29
ATE299930T1 (de) 2005-08-15
KR100463366B1 (ko) 2004-12-29
HU9600789D0 (en) 1996-05-28
KR100432851B1 (ko) 2004-11-06
CA2172997A1 (en) 1995-04-06
DE69434433T2 (de) 2006-04-20
CN1078248C (zh) 2002-01-23
NO961268D0 (no) 1996-03-29
WO1995009231A1 (fr) 1995-04-06
BR9407682A (pt) 1997-02-04
FR2710654A1 (fr) 1995-04-07
NO317236B1 (no) 2004-09-27
KR960705028A (ko) 1996-10-09
HUT75985A (en) 1997-05-28
AU7815794A (en) 1995-04-18
FR2710654B1 (fr) 1995-12-22
FI961440A (sv) 1996-03-29
DK0721500T3 (da) 2005-10-17
US5902577A (en) 1999-05-11
EP0721500A1 (fr) 1996-07-17
HU219826B (hu) 2001-08-28
CN1134724A (zh) 1996-10-30
EP0721500B1 (fr) 2005-07-20
ES2243929T3 (es) 2005-12-01
KR20040017357A (ko) 2004-02-26
JP2005185293A (ja) 2005-07-14
DE69434433D1 (de) 2005-08-25
AU688383B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
Bearzi et al. PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium
Harris et al. The potential of cord blood stem cells for use in regenerative medicine
Harris Non‐haematological uses of cord blood stem cells
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
DE69634828D1 (de) Auffindbare künstliche bioimplantate
PL346520A1 (en) Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
FI961440A0 (sv) Cellinjer som avsöndrar insulin, framställningsförfaranden och användning
ATE320483T1 (de) Isolierung und züchtung von schwannzellen
WO2003072728A3 (en) Cellular trans-differentiation
Klinger et al. Relevance and safety of telomerase for human tissue engineering
Triolo et al. Lessons from human islet transplantation inform stem cell-based approaches in the treatment of diabetes
Müller‐Ehmsen et al. Cellular cardiomyoplasty—a novel approach to treat heart disease
CA2488414A1 (en) Primary cultured adipocytes for gene therapy
WO1986001530A1 (en) A process for proliferation of wholly or partially differentiated beta-cellls
El-Sabbagh Modern trends in lipomodeling
Ahn et al. Reconstruction of rabbit corneal epithelium on lyophilized amniotic membrane using the tilting dynamic culture method
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin
Oberholzer et al. β Cell Replacement for the Treatment of Diabetes
Woodard et al. Re: measurement of chimerism after hematopoietic stem cell transplantation
Matsumoto et al. Allogeneic Islet Transplantation and Future
House et al. Effect of serial transplantation on the growth of neonatal pancreas in the hamster
EP0328420A3 (en) Gangliosides containing de-n-acetyl-sialic acid and their applications as modifiers of cell physiology
Rajan Insulin and Glucagon Secretion In Vitro
EP0291164A3 (en) Growth-suppressing infusion medium, growth-suppressing cell culture medium and processes for the suppression of transformed cell growth
Katz Biomaterials in the 21st century revisited!: J Lawrence Katz Ph. D.

Legal Events

Date Code Title Description
FD Application lapsed